Site 122

Milan 20141

1 studies enrolling now · 2 studies all time

What they study most

Fallopian Tube Neoplasms, Head and Neck Squamous Cell Carcinoma, Ovarian Neoplasm, Peritoneal Neoplasms

Studies at this site

• A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1) — Recruiting now
• Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer — Running, not enrolling